Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMDP) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for LifeMD (LFMDP) over the last 14 years, with Q3 2025 value amounting to $66.0 million.

  • LifeMD's Liabilities and Shareholders Equity fell 906.36% to $66.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $289.3 million, marking a year-over-year increase of 1285.22%. This contributed to the annual value of $76.1 million for FY2024, which is 3012.2% up from last year.
  • Per LifeMD's latest filing, its Liabilities and Shareholders Equity stood at $66.0 million for Q3 2025, which was down 906.36% from $73.6 million recorded in Q2 2025.
  • LifeMD's 5-year Liabilities and Shareholders Equity high stood at $76.1 million for Q4 2024, and its period low was $16.4 million during Q3 2021.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $40.7 million (2023), whereas its average is $46.7 million.
  • In the last 5 years, LifeMD's Liabilities and Shareholders Equity skyrocketed by 71812.78% in 2021 and then plummeted by 4858.94% in 2022.
  • LifeMD's Liabilities and Shareholders Equity (Quarter) stood at $49.9 million in 2021, then crashed by 48.59% to $25.7 million in 2022, then skyrocketed by 127.85% to $58.5 million in 2023, then skyrocketed by 30.12% to $76.1 million in 2024, then fell by 13.29% to $66.0 million in 2025.
  • Its last three reported values are $66.0 million in Q3 2025, $73.6 million for Q2 2025, and $73.6 million during Q1 2025.